GLP-1 Weight Loss Starter Guide: What to Know First

Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery

Key Takeaways

• GLP-1 receptor agonists support meaningful weight loss by reducing appetite and improving insulin sensitivity under medical supervision.
• Thorough eligibility screening with a full lab review helps identify contraindications and allows safe, tailored treatment.
• A slow, stepwise titration schedule reduces side effects and gives your body time to adjust to each dose.
• Protein-focused eating and consistent hydration help preserve muscle and ease common gastrointestinal side effects.
• At Mirror Plastic Surgery, Ellie Pranckevicius provides personalized protocols and ongoing support. Book your consultation today to begin supervised GLP-1 therapy.

GLP-1 Eligibility and Lab-First Screening

Adults with a BMI of 30 or higher, or a BMI of at least 27 with a weight-related condition such as type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, cardiovascular disease, or metabolic-associated steatohepatitis (MASH), are generally considered eligible candidates. Candidacy must be determined by a clinician after a full medical history review and physical examination.

GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). They are typically not recommended during pregnancy and are used with caution in those with a history of pancreatitis.

At Mirror Plastic Surgery, Ellie begins with a comprehensive review of thyroid, liver, kidney, diabetes markers, and hormone panels. If current lab results are unavailable, she orders them before any protocol starts. This lab-first approach keeps treatment safe and tailored to each person’s metabolic baseline.

Core GLP-1 Terms You Will Hear

• GLP-1 receptor agonists: Synthetic peptides that bind to glucagon-like peptide-1 receptors, reduce appetite, slow digestion, and support weight loss and blood sugar control.
• Titration: A gradual increase in medication dose over weeks or months so the body can adapt and side effects stay manageable.
• Protein prioritization: A way of eating that centers each meal around high-quality protein to help preserve lean muscle during calorie reduction.
• GLP-3R: A newer-generation peptide compound with a similar pathway to GLP-1, a reported more comfortable side-effect profile, lower muscle wasting risk, and broader indications such as insulin resistance and cardiovascular risk factor management.

Practitioner Expertise: Meet Ellie Pranckevicius, FNP-BC

Given the complexity of GLP-1 medications and the need for careful titration and monitoring, experienced guidance matters. Ellie Pranckevicius is a board-certified Family Nurse Practitioner and the lead practitioner for peptide therapies at Mirror Plastic Surgery. She holds a Bachelor’s in Health Science from Boston University, completed an aesthetics licensure program, and earned both her Bachelor’s and Master’s in Nursing from the University of South Florida. Four years in the Neuroscience ICU at Tampa General Hospital gave her deep experience with physiology, metabolic health, and complex patient care.

Ellie focuses on education and clear explanations. She breaks down the physiology behind every recommendation so patients understand what they are taking and why. She often advises patients to delay or skip therapy when it is not yet appropriate, placing long-term health above short-term revenue. Her work is supported by the clinical oversight of Dr. Akash Chandawarkar, MD, a Harvard-educated physician, Johns Hopkins-trained plastic surgeon, and founder of Mirror Plastic Surgery.

Book an appointment with Ellie to start with a full lab review and a personalized protocol.

Step-by-Step: How GLP-1 Therapy Works at Mirror

1. Consultation: A 30–60 minute visit with Ellie covering medical history, current medications, weight history, and wellness goals.
2. Lab review: Thyroid, liver, kidney, metabolic, and hormone panels are reviewed or ordered to confirm eligibility and set a baseline.
3. Protocol selection: Based on labs and clinical profile, Ellie selects semaglutide, tirzepatide, or a GLP-3R compound and sets the starting dose.
4. Administration training: Patients receive clear reconstitution and self-injection instructions, often supported by video demonstrations.
5. Ongoing monitoring: Regular check-ins track weight, side effects, and lab markers. Ellie adjusts the dose based on individual response.
6. Concierge support: Patients have direct text access to Ellie for questions, side-effect support, and refill coordination throughout treatment.

Beginner Semaglutide Dosing Schedule

Semaglutide titration follows a deliberate “start low, go slow” plan over several months to reduce gastrointestinal side effects. The table below outlines the standard injectable semaglutide schedule used in most supervised programs.

Phase	Weeks	Weekly Dose	Clinical Notes
Initiation	1–4	0.25 mg	Starter dose, never skip this phase
Escalation 1	5–8	0.5 mg	Check GI tolerance before moving up
Escalation 2	9–12	1.0 mg	Most patients notice strong appetite suppression here
Escalation 3	13–16	1.7 mg	Ellie may hold this dose if side effects persist
Maintenance	17+	2.4 mg	Lowest effective dose used for long-term maintenance

Dose increases should not occur sooner than every four weeks without direct provider instruction. Tirzepatide follows a similar stepwise escalation and appears in the comparison section below. All dosing at Mirror Plastic Surgery is individualized, so this schedule serves as a general reference rather than a self-prescribing guide.

Protein-First Eating on GLP-1 Therapy

Up to 39% of weight lost on semaglutide can be lean body mass, compared to 20–30% with diet and exercise alone, which makes adequate protein intake critical for patients on GLP-1 medications. The targets below apply from the first week of treatment.

Nutrient Target	Daily Goal	Priority Foods
Protein	60 g minimum	Chicken, fish, eggs, Greek yogurt, legumes
Fiber (women)	21 g+	Vegetables, berries, oats, chia seeds
Fiber (men)	30 g+	Whole grains, beans, nuts, seeds
Hydration	64–80 oz water	Plain water, with limited carbonated beverages

• Build every meal around a protein source, then add carbohydrates and fats.
• An over-the-counter fiber supplement is often recommended at the start of GLP-1 therapy to help prevent constipation.
• Limit ultra-processed foods, added sugars, and high-fat fried items, which can worsen nausea.
• Choose nutrient-dense whole foods such as lean proteins, fruits, vegetables, nuts, seeds, and whole grains to pack more nutrition into smaller portions.

Managing GLP-1 Side Effects Week by Week

Most GLP-1 side effects involve the gastrointestinal system and peak during dose increases. The timeline below reflects common experiences during the first 90 days.

1. Weeks 1–4 (0.25 mg): Mild nausea, reduced appetite, and occasional fatigue are common. Eat small, frequent meals and stay upright after eating.
2. Weeks 5–8 (0.5 mg): Nausea may rise briefly after the dose change. Constipation often appears, so increase fiber and water and consider a fiber supplement.
3. Weeks 9–12 (1.0 mg): GI symptoms usually stabilize. Some patients notice intermittent bloating or heartburn. Avoid carbonated drinks and very large meals.
4. Weeks 13–16 (1.7 mg): Another short-lived nausea spike can occur with escalation. Protein-first eating and steady hydration remain the main tools.
5. Weeks 17+ (maintenance): Most patients report much better tolerability. Patients who do not tolerate 2.4 mg may remain at 1.7 mg as a maintenance dose.

Persistent vomiting, severe abdominal pain, or signs of dehydration require immediate contact with your provider. Ellie’s direct-text concierge access allows patients at Mirror Plastic Surgery to reach her as soon as a concern appears.

Semaglutide, Tirzepatide, and GLP-3R: Comparing Options for Beginners

Now that the side-effect timeline is clear, it helps to understand how different agents feel in practice. The three options below differ in mechanism, tolerability, and suitability for first-time users. GLP-3R data come from emerging clinical observations and Mirror Plastic Surgery’s experience with compounded formulations. Head-to-head randomized trial data comparing all three agents are not yet available, so this comparison focuses on qualitative clinical characteristics rather than shared numerical endpoints.

Agent	Mechanism	Tolerability Notes for Beginners	Muscle Preservation Profile
Semaglutide	GLP-1 receptor agonist	Well-characterized titration, GI side effects usually manageable with slow escalation	Up to 39% of weight lost may be lean mass, so protein intake is critical
Tirzepatide	Dual GLP-1 / GIP receptor agonist	Comparable GI profile to semaglutide, with required stepwise titration	Dual agonism may offer modest added metabolic benefit, while protein intake remains essential
GLP-3R (compounded)	Newer-generation GLP receptor agonist	Reported fewer GI symptoms than older GLP-1 agents, with early but encouraging tolerability data	Reported lower muscle wasting risk and broader indications including insulin resistance and cardiovascular risk factors

The right agent depends on lab results, medical history, and tolerance. Ellie reviews all three options during consultation and recommends the protocol that best fits each patient’s profile.

Book an appointment with Ellie to choose the agent that matches your metabolic needs.

GLP-1 Trends and New Developments

As of March 2026, the FDA approved a higher 7.2 mg weekly dose of semaglutide for appropriate patients after the STEP UP trial in The Lancet Diabetes & Endocrinology. That study showed patients on 7.2 mg lost an average of 20.7% of starting body weight over 72 weeks.¹ Dual and triple receptor agonists are moving through clinical pipelines, and compounded GLP-3R formulations are gaining attention among practitioners who want agents with improved tolerability and broader metabolic indications. The field changes quickly, so patients benefit from a provider who tracks new evidence through ongoing clinical education, a standard Ellie maintains.

Key Practical Considerations Before You Start

Several practical factors shape both safety and expectations before starting GLP-1 therapy. Sourcing comes first. Peptides from unverified online retailers lack guarantees of purity, accurate dosing, and sterility, so Mirror Plastic Surgery uses only suppliers with rigorous batch testing.

As discussed in the eligibility section, clinical supervision with full medical review is non-negotiable before therapy begins. Once supervised treatment starts, realistic timelines matter. The STEP 1 clinical trial showed that semaglutide at 2.4 mg produced average weight loss of 14.9% of starting body weight over 68 weeks.¹ Individual results vary based on adherence, diet, activity level, and metabolic factors.

Long-term planning also plays a major role. Obesity is a chronic disease, and abrupt discontinuation of GLP-1 therapy often leads to rapid weight regain. A maintenance protocol usually becomes necessary to sustain results.

Risks, Limitations, and Common Challenges

• GI symptoms: Diarrhea and constipation occur frequently with GLP-1 use, so fiber management and hydration should start on day one.
• Muscle loss: Given the elevated muscle loss risk discussed earlier, protein intake becomes especially important. Patients need more nutrition in smaller portions, which makes nutrient density essential.
• Unsupervised online sources: Without third-party batch testing, product content remains unknown. Incorrect dosing without screening for pre-existing conditions or current medications can cause serious adverse events.
• Contraindications: Contraindications and metabolic conditions require clinical screening before any GLP-1 therapy begins.

Common Misconceptions About GLP-1 Therapy

• “Results are immediate.” Meaningful weight loss usually appears after several weeks at therapeutic doses. The titration phase focuses on safety and tolerability, not speed.
• “GLP-1 therapy is suitable for everyone.” Contraindications, drug interactions, and metabolic conditions make proper screening essential before starting.
• “Effects are permanent.” Weight regain after stopping therapy is well documented. Long-term maintenance plans and lifestyle habits drive lasting outcomes.
• “Higher doses produce faster results.” Starting at a higher dose is never appropriate. The titration schedule outlined earlier is a critical safety measure, not a suggestion.

Frequently Asked Questions

How long does it take to see weight loss results on GLP-1 therapy?

Most patients notice reduced appetite within one to two weeks.¹ Measurable weight loss usually becomes consistent after reaching a therapeutic dose, which often takes two to four months with the standard titration schedule.¹ Clinically significant results, often defined as 5% or more of starting body weight, are generally seen between months three and six.¹ Timelines vary based on starting weight, diet, activity level, and the specific agent used.

Can I get GLP-1 therapy without a lab panel?

At Mirror Plastic Surgery, lab review is a required part of the intake process for weight loss therapy. Thyroid, liver, kidney, metabolic, and hormone panels are reviewed before any protocol begins. This step identifies contraindications, sets a metabolic baseline, and helps Ellie choose the most appropriate agent and starting dose for your physiology. Skipping labs raises the risk of adverse events and lowers the chance of strong results.

What is GLP-3R and how does it differ from semaglutide?

GLP-3R is a newer compounded peptide that acts on GLP receptor pathways similar to semaglutide but with a reported improvement in tolerability, a lower muscle wasting risk, and broader metabolic indications such as insulin resistance and cardiovascular risk factor management. It does not replace semaglutide or tirzepatide in every case. The right choice depends on lab results, medical history, and treatment goals. Ellie reviews all three options during consultation and recommends the protocol that fits each patient best.

What happens if I stop GLP-1 therapy after reaching my goal weight?

Stopping GLP-1 therapy abruptly after reaching goal weight often leads to weight regain because the hormonal appetite suppression no longer supports you. Most supervised programs shift patients into a maintenance phase at the lowest effective dose rather than stopping completely. Sustainable dietary habits, especially steady protein intake and fiber targets, help preserve results. Ellie works with patients to design a long-term maintenance strategy that fits their lifestyle and metabolic profile.

Is it safe to use GLP-1 medications purchased online without a prescription?

Using GLP-1 or peptide compounds from unverified online sources carries significant risk. Without third-party batch testing, the actual content, purity, and dose remain unknown. There is no clinical screening for contraindications, no titration guidance, and no support if side effects occur. Serious adverse events, including those related to the thyroid contraindications discussed in the eligibility section or active pancreatitis, are possible without proper screening. Medically supervised therapy with a qualified practitioner, full lab review, and quality-verified sourcing remains the standard of care for GLP-1 weight loss treatment.

Conclusion and Next Steps with Mirror Plastic Surgery

GLP-1 therapy represents a major advance in weight management, and its safety and effectiveness depend on how it is started and managed. Proper eligibility screening, slow titration, protein-first nutrition, proactive side-effect support, and long-term maintenance planning form the core of a sound protocol. Newer agents such as GLP-3R expand options for first-time users, especially those who worry about tolerability or muscle preservation.

Mirror Plastic Surgery delivers this level of care through Ellie Pranckevicius’s concierge model, which includes comprehensive lab review, individualized protocol selection, direct ongoing access, and quality-verified sourcing. Consultations are available in person at the St. Petersburg office or remotely across the United States.

Book an appointment with Ellie to start your GLP-1 journey with a full lab review and a protocol built around your specific goals.

Disclaimer: The information in this article is intended for educational purposes only and does not constitute medical advice. GLP-1 receptor agonists and peptide therapies should only be initiated under the supervision of a qualified healthcare provider following a thorough clinical evaluation. Individual results vary. Mirror Plastic Surgery’s peptide therapies are not FDA-regulated. Consult your provider before starting, stopping, or modifying any medical treatment.

---